SPM-927 (Schwarz Pharma).
作者信息
Hovinga Collin A
机构信息
The Cleveland Clinic Foundation, Departments of Neurology/Pharmacy, 9500 Euclid Ave-S51, Cleveland, OH 44195, USA.
出版信息
IDrugs. 2003 May;6(5):479-85.
PMID:12789603
Abstract
Schwarz Pharma, under license from Harris FRC, is developing SPM-927, synthesized by researchers at the University of Houston, for the potential treatment of epilepsy and neuropathic pain.
摘要
Zotero 插件